Invention Grant
US08852588B2 Treating allergic airway disorders using anti-IL-20 receptor antibodies
有权
使用抗IL-20受体抗体治疗过敏性气道障碍
- Patent Title: Treating allergic airway disorders using anti-IL-20 receptor antibodies
- Patent Title (中): 使用抗IL-20受体抗体治疗过敏性气道障碍
-
Application No.: US13568666Application Date: 2012-08-07
-
Publication No.: US08852588B2Publication Date: 2014-10-07
- Inventor: Ming-Shi Chang
- Applicant: Ming-Shi Chang
- Applicant Address: TW Tainan
- Assignee: National Cheng Kung University
- Current Assignee: National Cheng Kung University
- Current Assignee Address: TW Tainan
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/24

Abstract:
Treatment of an allergic airway disorder (e.g., asthma or bronchial airway obstruction) using anti-IL-20R1 antibodies such as mAb51D, mAb7GW, or functional variants thereof.
Public/Granted literature
- US20140044715A1 TREATING ALLERGIC AIRWAY DISORDERS USING ANTI-IL-20 RECEPTOR ANTIBODIES Public/Granted day:2014-02-13
Information query